🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase III trial studies how well hypofractionated radiation...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-07-28
Trial ID
NCT03274687
Our objective is based on a personalized approach of adjuvant breast radiot...
Status
Recruiting
Location
Institut Du Cancer de Montpellier
Start Date
2025-03-06
Trial ID
NCT06382818
There is a strong radiobiological and economic rationale for hypofractionat...
Status
Active Not Recruiting
Location
University of Texas Southwestern Medical Center
Start Date
2020-07-28
Trial ID
NCT04403620
Treatments Being Tested
This study is the first prospective, randomized phase III clinical trial de...
Status
Recruiting
Location
Samsung Medical Center
Start Date
2026-03-06
Trial ID
NCT07500701
Background:Moderate three week hypofractionated adjuvant radiotherapy sched...
Status
Recruiting
Location
Sanjoy Chatterjee
Start Date
2019-03-26
Trial ID
NCT03788213
For unresectable locally advanced non-small cell lung cancer (LA-NSCLC), th...
Status
Active Not Recruiting
Location
Jiangsu Cancer Hospital
Start Date
2022-10-27
Trial ID
NCT05784142
Treatments Being Tested
The purpose of this study is to investigate whether radiotherapy given as t...
Status
Unknown
Location
Canberra Hospital
Start Date
2009-12
Trial ID
NCT01014130
Treatments Being Tested
The aim of this trial is to compare the safety outcomes of Hypofractionated...
Status
Recruiting
Location
Changhai hospital
Start Date
2024-02-01
Trial ID
NCT06325995
Treatments Being Tested
This phase II trial studies the wound complication risk of shorter course, ...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2018-12-17
Trial ID
NCT03819985
Treatments Being Tested
Gastric cancer is the third leading cause of death due to cancer worldwide....
Status
Completed
Location
Jiangsu Cancer Hospital
Start Date
2023-06-10
Trial ID
NCT05941481
Treatments Being Tested